Slotnik Capital, LLC
DALLAS, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$303.0M2026 Q3+ $6.8M options (notional, not included)
Positions28
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.70.2%
What Changed This Quarter?
Top Holdings
GSAT
Globalstar
10.2%
PEN
Penumbra
9.6%
MKTX
Marketaxess
9.2%
TECH
Bio-Techne
7.5%
ITGR
Integer
6.5%
ROKU
Roku
6.0%
ATKR
Atkore
6.0%
KVUE
Kenvue
5.4%
New / Increased
14 new · 5 increased
MKTXNEW
Marketaxess
9.2%
ITGRNEW
Integer
6.5%
ATKRNEW
Atkore
6.0%
PSNLNEW
Personalis
4.9%
BWINNEW
Baldwin Insurance Grp
4.0%
ACA
Arcosa
5.0%
+135.2%
ROKU
Roku
6.0%
+79.4%
TECH
Bio-Techne
7.5%
+54.9%
Reduced / Exited
6 reduced · 14 sold out
PEN
Penumbra
9.6%
-30.1%
KVUE
Kenvue
5.4%
-41.7%
RNA
Atrium Therapeutics
0.1%
-83.2%
NSC
Norfolk Southn
1.5%
-16.7%
AVO
Mission Produce
1.5%
-15.5%
TMHC*EXIT
Taylor Morrison Home
9.9%
Apogee Therap…EXIT
Apogee Therapeutics
8.9%
GTLSGBPEXIT
Chart Industries
7.0%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.